Breast Cancer and Exercise Trial in Alberta: The BETA Trial
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention
Insulin Resistance
Measurements taken of Insulin Levels, Glucose Levels, Insulin Resistance (HOMA Score)
36 Months
No
Christine Friedenreich, BSc, MSc,PhD
Principal Investigator
Tom Baker Cancer Centre
Canada: Health Canada
ACF:24404
NCT01435005
March 2010
Name | Location |
---|